Handelsavisen
prelaunch
23
2321.HK HKEX Food Retail & Distribution

2321.Hk

HK$0,48
Open in Charts → Attach watcher ⌖
HKD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
485,1M HKD
P/E
EV / Rev
Div yield
Op margin
4,7 %
ROE
12,1 %
Net margin
3,6 %
Debt / equity
0,33
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

The company operates in the Food & Drug Retailing sector, generating revenue primarily through the retail sale of food and drug products.

Business. The company operates in the Food & Drug Retailing sector, generating revenue primarily through the retail sale of food and drug products.

Classification92 %
SectorConsumer Non-Cyclicals
Business sectorFood & Drug Retailing
IndustryFood Retail & Distribution
ActivityFood & Drug Retailing
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
12,1 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 2321.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples · THIS SECTOR−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 2321.HK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    The company operates in the Food & Drug Retailing sector, generating revenue primarily through the retail sale of food and drug products.

    Classification92 %
    SectorConsumer Non-Cyclicals
    Business sectorFood & Drug Retailing
    IndustryFood Retail & Distribution
    ActivityFood & Drug Retailing
    AI synthesis
    GENERATED

    The company maintains a market price of MYR 0.48, with a market capitalization of MYR 480.08 million, and a price-to-earnings ratio of 14.44, indicating a moderate valuation relative to earnings. The price-to-book ratio of 1.75 suggests that the company's market value is 75% higher than its book value, reflecting investor confidence in its intangible assets and future earnings potential. The company's liquidity position is characterized by a current ratio of 2.91, which is above the industry median, indicating a strong ability to meet short-term obligations. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints.

    In terms of profitability, the company reports a return on equity (ROE) of 12.14% and a return on assets (ROA) of 7.43%, both of which are above the industry median, suggesting efficient use of equity and assets to generate profit. The operating margin, calculated as operating income of MYR 44.21 million on revenue of MYR 932.89 million, is 4.74%, which is in line with the industry average. The company's gross profit margin of 13.07% is also consistent with the industry median, indicating that it is effectively managing its cost of goods sold.

    The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification, which may expose it to regional economic fluctuations. The company's debt-to-equity ratio of 0.33 is below the industry median, indicating a conservative capital structure with limited leverage. The company's total liabilities of MYR 173.55 million are significantly lower than its total equity of MYR 273.68 million, further supporting its financial stability.

    Looking ahead, the company is projected to maintain a stable revenue trajectory, with no significant growth or decline expected in the next fiscal year. The company's long-term debt of MYR 89.74 million is manageable given its equity base, but any increase in debt could affect its credit profile. The company's risk assessment indicates a medium liquidity risk and a low dilution risk, with no immediate pressure for equity issuance. The company's financial structure is supported by a strong equity base, but its negative net cash position may require monitoring.

    Recent filings and transcripts do not indicate any material events that would significantly impact the company's operations or financial position. The company's financial performance and risk profile remain stable, with no immediate concerns for investors.

    Key takeaways
    • The company has a moderate valuation with a price-to-earnings ratio of 14.44 and a price-to-book ratio of 1.75.
    • The company's profitability metrics, including ROE of 12.14% and ROA of 7.43%, are above the industry median.
    • The company's capital structure is conservative, with a debt-to-equity ratio of 0.33 and a current ratio of 2.91.
    • The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification.
    • The company's liquidity position is medium risk, with a negative net cash position after subtracting total debt.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    HK$0,48
    Market cap
    HK$480.1M
    Enterprise value
    HK$569.8M
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    1.8x
    P / Tangible book
    1.8x
    Tangible book
    HK$273.7M
    Net cash
    -HK$89.7M
    Current ratio
    2.9
    Debt / equity
    0.3
    ROA
    7.4%
    ROE
    12.1%
    Cash conversion
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin4,7 %Above median
    Net Margin3,6 %Above median
    ROE12,1 %Above median
    D/E0,33Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Return On Equity
      net_income / total_equity
    • Price To Earnings
      market_price / (net_income / shares_outstanding_diluted)
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • 2321.HK Market data — financials · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    2321.HKCanonical
    HKEX · HKD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage